Article
Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts.
Carcinogenesis - 1 Jun 2009
Zibat Arne, Uhmann Anja, Nitzki Frauke, Wijgerde Mark, Frommhold Anke, Heller Tanja, Armstrong Victor, Wojnowski Leszek, Quintanilla-Martinez Leticia, Reifenberger Julia, Schulz-Schaeffer Walter, Hahn Heidi
Abstract excerpt
Mutations in Patched (PTCH) have been associated with tumors characteristic both for children [medulloblastoma (MB) and rhabdomyosarcoma (RMS)] and for elderly [basal cell carcinoma (BCC)]. The determinants of the variability in tumor onset and histology are unknown. We investigated the effects of the time-point and dosage of Ptch inactivation on tumor spectrum using conditional Ptch-knockout mice. Ptch...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
